Loading...
Back to narrative

MRX: US Expansion Will Drive Future Upside Despite Pending Securities Lawsuits

Update shared on 09 Dec 2025

Fair value Decreased 2.62%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
30.6%
7D
0.9%

Narrative Update on Marex Group Price Target

Analysts have modestly reduced their averaged price target on Marex Group from approximately $49.00 to about $47.70. This reflects slightly weaker top line growth assumptions, partially offset by expectations for improved profit margins and a marginally lower future price to earnings multiple.

What's in the News

  • Marex Group has launched a US structured products business targeting RIAs, broker dealers, and private banks, led by new Head of US Distribution Scott Kerbel. The initiative aims to offer diversified non bank issuance, faster product turnaround, and transparent pricing (Key Developments).
  • The company is actively pursuing acquisitions, with CEO Ian Lowitt highlighting a strong and disciplined M&A pipeline for the remainder of the year and into 2026 (Key Developments).
  • Levi & Korsinsky has notified investors of a securities class action lawsuit alleging that Marex improperly inflated cash flow and Market Making segment results through off book intercompany transactions, with a lead plaintiff deadline of December 8, 2025 (Key Developments).
  • Scott+Scott has filed a separate securities class action on behalf of short sellers, also alleging that Marex overstated cash flow and Market Making revenues, assets, and profits via off book intercompany transactions, leading to losses when the information emerged (Key Developments).
  • Marex has issued guidance for the quarter ended September 30, 2025, projecting revenue of $475 million to $485 million, profit before tax of $94 million to $99 million, and diluted EPS of $0.88 to $0.93 (Key Developments).

Valuation Changes

  • Fair Value: Reduced modestly from approximately $49.00 to about $47.70 per share, reflecting a slightly lower intrinsic value estimate.
  • Discount Rate: Effectively unchanged at around 13.46 percent, indicating no material shift in perceived risk or required return.
  • Revenue Growth: The forecast decline has deepened from about negative 7.8 percent to roughly negative 9.5 percent, signaling a more cautious outlook on top line performance.
  • Net Profit Margin: Increased slightly from roughly 18.9 percent to about 20.0 percent, implying expectations for modestly better profitability.
  • Future P/E: Trimmed marginally from about 13.77x to approximately 13.41x, pointing to a slightly lower valuation multiple on forward earnings.

Have other thoughts on Marex Group?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.